Elicera Therapeutics AB (ELIC) — Financial Flexibility Index
Elicera Therapeutics AB (ELIC) has a Financial Flexibility Index of -0.68x as of September 2025. Free cash flow of Skr-4.74 Million (operating CF Skr-4.74 Million minus capex Skr0.00) represents -1% of total liabilities (Skr6.97 Million). Check total reinvestment intensity of Elicera Therapeutics AB to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Elicera Therapeutics AB Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Elicera Therapeutics AB across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does Elicera Therapeutics AB generate cash.
Annual Financial Flexibility Index for Elicera Therapeutics AB (2017–2024)
Year-by-year free cash flow to debt coverage for Elicera Therapeutics AB. Explore Elicera Therapeutics AB (ELIC) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.45x | Skr-23.46 Million | Skr-23.46 Million | Skr6.79 Million | ▼ -219.0% |
| 2023 | -1.08x | Skr-14.92 Million | Skr-14.92 Million | Skr13.78 Million | ▼ -70.7% |
| 2022 | -0.63x | Skr-8.57 Million | Skr-8.57 Million | Skr13.51 Million | ▲ +88.9% |
| 2021 | -5.72x | Skr-14.29 Million | Skr-14.29 Million | Skr2.50 Million | ▼ -1489.8% |
| 2020 | -0.36x | Skr-846.37K | Skr-905.25K | Skr2.35 Million | ▲ +99.4% |
| 2019 | -59.79x | Skr-239.16K | Skr-239.16K | Skr4.00K | ▲ +0.0% |
| 2018 | -59.79x | Skr-239.16K | Skr-239.16K | Skr4.00K | ▲ +0.0% |
| 2017 | -59.79x | Skr-239.16K | Skr-239.16K | Skr4.00K | — |